NASDAQ NMS - GLOBAL MARKET · ELUT
+0.06% · $0.0000 · Vol 20.0K
Market closed · last close 4:00 PM ET · price as of 19:01:15 ET
Elutia Inc

Elutia Inc

Biotechnology
$0.8278
Card
Relationship Map

Follow $ELUT

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $ELUT by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
ELUT
Elutia Inc
Fri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

63/ 100
Veridion Score
Upper range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Fri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ELUT moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ELUT catalysts
About Elutia Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2020
Employees
26
Country
US

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.8200
Day high
$0.8346
Day low
$0.7901
Previous close
$0.8273
52W high
$1.22
-32.15% from high
52W low
$0.5050
45% of range
Market cap
$36.6M
P/E
0.70×
EPS
$1.22
Beta
0.09
Shares out
44.3M
Volume
20K
0.07× rel vol
Avg volume
303K
VWAP
$0.8070
Price history computed in-house
1W
+6.31%
1M
+3.45%
3M
-14.04%
1Y
-6.99%
YTD
+19.50%
SMA 50 $0.8521 · below
SMA 200 $0.9626 · below
52W position 45%

ELUT overview

Veridion Score
63
Registered · 2026-10-09
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ELUT.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ELUT Form 4 filings
Public disclosures

Congress activity in ELUT

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

ELUT contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ELUT in this window.
Lobbying spend

ELUT lobbying filings, year to date.

Registered lobbying filings matched to Elutia Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ELUT in this window.
Loading news for ELUT
Analyst ratings
Sovereign unlock shows live analyst consensus for ELUT.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.